Literature DB >> 11899067

Multivariate pharmaceutical profiling for drug discovery.

Edward H Kerns1, Li Di.   

Abstract

The field of pharmaceutical profiling in drug discovery is described. The pharmaceutical properties of drug candidates determine how much of the drug safely reaches the therapeutic target. Drug candidates often fail in discovery and development due to inadequate properties, resulting in lost opportunities and resources for developing new drugs. Pharmaceutical profiling assays have been developed and implemented to measure the properties of large numbers of drug candidates starting at the earliest stages of discovery. This information is used for informed decisions in drug candidate selection and synthetic optimization. A holistic process of parallel activity and property optimization has emerged in drug discovery. The assays, strategies, and data management associated with pharmaceutical profiling are discussed.

Mesh:

Year:  2002        PMID: 11899067     DOI: 10.2174/1568026023394470

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  2 in total

1.  Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis.

Authors:  Yinan Zhang; Kevin Tianmeng Zhao; Susan G Fox; Jinho Kim; Donald R Kirsch; Robert J Ferrante; Richard I Morimoto; Richard B Silverman
Journal:  J Med Chem       Date:  2015-07-31       Impact factor: 7.446

2.  Use of the Biopharmaceutical Classification System in early drug development.

Authors:  M Sherry Ku
Journal:  AAPS J       Date:  2008-04-03       Impact factor: 4.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.